A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2004
11/17/2004	EP1477496A1 Peg-conjugated pth or peg-conjugated pth derivate
11/17/2004	EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1477165A2 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
11/17/2004	EP1476153A2 Method of treating and preventing bone loss
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0777491B1 Use of tasteless, hydrolysed collagen and agent containing the same
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547578A Aminopyrrole compounds as antiinflammatory agents
11/17/2004	CN1547486A Antibodies to OPGL
11/17/2004	CN1547478A Use of fucans in the treatment of adhesions, arthritis and psoriasis
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546169A Transnasal inhalant dry powder of calcitonin and its preparation
11/17/2004	CN1546148A Ointment for expelling the wind and cold, removing toxic substances, removing blood stasis and its preparation
11/17/2004	CN1546140A Medicinal composition for treating hyperosteogeny and protrusion of lumber intervertebral disc and its preparation
11/17/2004	CN1546134A Prescription and preparing process and preparation of Wugen capsule
11/17/2004	CN1546131A Specific medicine for treating necrosis of femoral head
11/17/2004	CN1546129A Preparing technics of composition of Guizhi and Fuling and its use
11/17/2004	CN1546123A Chinese traditional medicine for treating bone fracture and osteopathy
11/17/2004	CN1546119A Externally applied plaster for treating knee-joint pain caused by wind dampness
11/17/2004	CN1546102A Pain alleviating plaster for periarthritis humeroscapularis and its preparation
11/17/2004	CN1546092A Blood stasis eliminating powder
11/17/2004	CN1546033A Orally disintegrating tablet of meloxicam and its preparation
11/17/2004	CN1546030A Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
11/17/2004	CN1546015A Composition containing amino acid calcium and soy isoflavone
11/17/2004	CN1176092C Biphosphonate
11/17/2004	CN1175881C Medicine for treating ischemic necrosis of head of femur and preparation method thereof
11/17/2004	CN1175867C Chinese medicine capsule for treating rheumatism and protrusion of lumber interverterbral disc
11/17/2004	CN1175865C Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
11/17/2004	CN1175856C Cervical spondylosis treating traditional medicine granule and its preparation
11/17/2004	CN1175854C Bone-setting pain stopping paste
11/17/2004	CN1175852C Medicine for treating hyperosteogeny
11/17/2004	CN1175835C Medicine for treating cervical vertebra disease
11/17/2004	CN1175834C Chinese traditional medicine for treating narrow lumbar vetebra canal
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818623 Active hedgehog protein conjugate
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/11/2004	WO2004096829A2 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds
11/11/2004	WO2004096828A2 Novel method and intermediates for the preparation of 19-nor-steroid compounds
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096275A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096273A1 Methods for treating interleukin-6 related diseases
11/11/2004	WO2004096247A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096230A1 Remedy for rheumatoid arthritis
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224970 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds

1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 820